ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge.

ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge.

Live-attenuated strains of simian immunodeficiency virus (SIV) routinely confer apparent sterilizing immunity against pathogenic SIV challenge in rhesus macaques. Understanding the mechanisms of protection by live-attenuated SIV may provide important insights into the immune responses needed for pro...

Descripció completa

Dades bibliogràfiques
Autors principals:	Michael D Alpert, Jackson D Harvey, W Anderson Lauer, R Keith Reeves, Michael Piatak, Angela Carville, Keith G Mansfield, Jeffrey D Lifson, Wenjun Li, Ronald C Desrosiers, R Paul Johnson, David T Evans
Format:	Article
Idioma:	English
Publicat:	Public Library of Science (PLoS) 2012-01-01
Col·lecció:	PLoS Pathogens
Accés en línia:	https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1002890&type=printable

Ítems similars

Immunization with single-cycle SIV significantly reduces viral loads after an intravenous challenge with SIV(mac)239.
per: Bin Jia, et al.
Publicat: (2009-01-01)

Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge.
per: Arun K Sasikala-Appukuttan, et al.
Publicat: (2013-01-01)

Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection.
per: Sama Adnan, et al.
Publicat: (2016-12-01)

Innate Lymphoid Cells in HIV/SIV Infections
per: Spandan V. Shah, et al.
Publicat: (2017-12-01)

Defining HIV and SIV Reservoirs in Lymphoid Tissues
per: Claire Deleage, et al.
Publicat: (2016-06-01)

CD8 T cell response maturation defined by anentropic specificity and repertoire depth correlates with SIVΔnef-induced protection.
per: Sama Adnan, et al.
Publicat: (2015-02-01)

Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
per: José M. Martinez-Navio, et al.
Publicat: (2020-03-01)

Intra-dermal immunisation with SIV gag-based vaccines alone inhibits acquisition of SIVmac251
per: Almond N, et al.
Publicat: (2012-09-01)

Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy
per: B. Ling, et al.
Publicat: (2017-12-01)

GCM-SIV1.5: Optimal Tradeoff between GCM-SIV1 and GCM-SIV2
per: Ping Zhang
Publicat: (2023-01-01)

Distinct phenotype, longitudinal changes of numbers and cell-associated virus in blood dendritic cells in SIV-infected CD8-lymphocyte depleted macaques.
per: Caroline Soulas, et al.
Publicat: (2015-01-01)

Delineation and Modulation of the Natural Killer Cell Transcriptome in Rhesus Macaques During ZIKV and SIV Infections
per: Malika Aid, et al.
Publicat: (2020-04-01)

Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
per: Zhang X, et al.
Publicat: (2012-09-01)

Predictors of SIV recrudescence following antiretroviral treatment interruption
per: Mykola Pinkevych, et al.
Publicat: (2019-10-01)

OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption
per: H. King, et al.
Publicat: (2022-12-01)

Functional perturbation of classical natural killer and innate lymphoid cells in the oral mucosa during SIV infection
per: Haiying eLi, et al.
Publicat: (2013-01-01)

SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
per: Mortara Lorenzo, et al.
Publicat: (2006-08-01)

A tonsillar PolyICLC/AT-2 SIV therapeutic vaccine maintains low viremia following antiretroviral therapy cessation.
per: Panagiotis Vagenas, et al.
Publicat: (2010-09-01)

Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques.
per: Emily R Roberts, et al.
Publicat: (2016-12-01)

No evidence for ongoing replication on ART in SIV-infected macaques
per: Taina T. Immonen, et al.
Publicat: (2024-06-01)

Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.
per: Benjamin Varco-Merth, et al.
Publicat: (2024-08-01)

Expression and purification of nonglycosylated SIV proteins, and their use in induction and detection of SIV-specific immune responses.
per: Hanke, T, et al.
Publicat: (1994)

Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection.
per: Haiying Li, et al.
Publicat: (2014-12-01)

Effects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese rhesus macaques.
per: Binhua Ling, et al.
Publicat: (2014-01-01)

DNA/long peptide vaccination against conserved regions of SIV induces partial protection against SIVmac251 challenge.
per: Koopman, G, et al.
Publicat: (2013)

OP 2.5 – 00048 Targeting the SIV reservoir with Alemtuzumab
per: B. Varco-Merth, et al.
Publicat: (2022-12-01)

Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
per: Hamimi C, et al.
Publicat: (2012-09-01)

A recombinant herpesviral vector containing a near-full-length SIVmac239 genome produces SIV particles and elicits immune responses to all nine SIV gene products.
per: Young C Shin, et al.
Publicat: (2018-06-01)

Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.
per: Daniel Mendoza, et al.
Publicat: (2013-02-01)

SIV Evolutionary Dynamics in Cynomolgus Macaques during SIV-<i>Mycobacterium tuberculosis</i> Co-Infection
per: Kaho H. Tisthammer, et al.
Publicat: (2021-12-01)

Siv som faglig guru
per: Bente Ruud, et al.
Publicat: (2023-10-01)

Nef and HIV/SIV Replication
per: Peterlin Matija
Publicat: (2005-12-01)

SIV replication in human cells
per: Hiroaki eTakeuchi, et al.
Publicat: (2012-04-01)

Evidence for Env-V2 sieve effect in breakthrough SIV <sub>MAC251</sub> infections in rhesus monkeys vaccinated with Ad26/MVA and MVA/Ad26 constructs
per: Sina S, et al.
Publicat: (2012-09-01)

A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
per: Jensen K, et al.
Publicat: (2012-09-01)

SIV persists in lymphoid tissues despite alemtuzumab-induced CD4+ T cell depletion
per: A.A. Okoye, et al.
Publicat: (2017-12-01)

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques
per: Mohammad Arif Rahman, et al.
Publicat: (2023-04-01)

Maturation of protective immunity induced by SIVΔnef correlates with differential expression of transcription factors in SIV-specific CD8+ T cells
per: Billingsley JM, et al.
Publicat: (2012-09-01)

Cellular and humoral antigenic epitopes in HIV and SIV.
per: Nixon, D, et al.
Publicat: (1992)

Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
per: Archana V. Boopathy, et al.
Publicat: (2023-11-01)